Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 170INDUSTRY 124NETWORK 4INDIV 4FED 3

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Breast Neoplasms 265Leukemia 183Carcinoma, Non-Small-Cell Lung 168Lymphoma 159Lung Neoplasms 148Prostatic Neoplasms 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Ovarian Neoplasms 117Colorectal Neoplasms 115Sarcoma 108Central Nervous System Neoplasms 107Head and Neck Neoplasms 98Leukemia, Myeloid, Acute 95Multiple Myeloma 93Squamous Cell Carcinoma of Head and Neck 83Rectal Neoplasms 77Colonic Neoplasms 71Uterine Cervical Neoplasms 65Neoplasm Metastasis 65Neuroblastoma 64Carcinoma, Ovarian Epithelial 64Brain Neoplasms 64Neoplasms 63Fallopian Tube Neoplasms 62Lymphoma, Large B-Cell, Diffuse 61Astrocytoma 59Melanoma 58Leukemia, Lymphocytic, Chronic, B-Cell 56Burkitt Lymphoma 56Hodgkin Disease 55

Interventions

Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Myasthenia Gravis × Clear all
NCT06342544 2026-01-21

IMCOMG

Fondation Ophtalmologique Adolphe de Rothschild

Phase 3 Recruiting
128 enrolled

Myasthenia Gravis

NCT07217509 2025-10-16

PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry

CorEvitas

Enrolling by invitation
1,500 enrolled

Myasthenia Gravis

NCT06259071 2024-02-14

MuSK 1000

Myasthenia Gravis Rare Disease Network

Unknown
1,000 enrolled

Myasthenia Gravis

NCT04667650 2020-12-16

MYASTEN

Fondation Ophtalmologique Adolphe de Rothschild

Completed
151 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡